To make that customer support more efficient, Ecolab uses Microsoft Dynamics 365 Remote Assist and Microsoft HoloLens 2 devices. The company’s experts now easily collaborate and help customers ...

Mount Sinai researchers have discovered for the first time a neural mechanism for memory integration that stretches across both time and personal experience. These findings, reported in Nature ...

A former Microsoft's HoloLens ... remote IT support and sponsor of Manchester United. This partnership aims to tap into the industrial market, allowing TeamViewer to provide remote support via the ...

Microsoft has ended production of its HoloLens 2 headsets, with no sign of a replacement ahead. UploadVR reports that ...

Hembree said partners can also use the HoloLens 2 as a more effective way to provide managed services with Microsoft's Dynamics 365 Remote Assist software. "They can remote assist and deliver ...

HoloLens 2 shows great potential over HoloLens 1 in terms of better compute power, the Azure Kinect Integration for full hand tracking and potentially object recognition, a larger field of view ...

To help achieve this goal, the company choose Microsoft HoloLens 2 and Dynamics 365 Remote Assist technologies to improve service technician efficiency, reduce time to problem resolution, and reduce ...

with production now ceased and software support on HoloLens 2 ending in December 2027. HoloLens launched in its original form back in 2016, offering a $3,000 USD mixed reality experience that ...

For more information, click here. The mission of the Mount Sinai Health System is to provide compassionate patient care with seamless coordination and to advance medicine. From the Editor Dating ...

Held the first Thursday of each month from 12:30 to 2:30 p.m. Paint like Bob Ross in a day with a certified Bob Ross instructor. step by step guidance. No experience needed. While creating your ...

Sinai Health System. “We’re looking forward to supporting the team at Mt. Sinai Health System with high quality clinical trial drug product,” said Nicholas Kadysh, CEO, PharmAla Biotech.